Clarion

Clarion Capital Partners Closes Oversubscribed $677 Million Fourth Fund; Announces Private Equity Leadership Promotion

Retrieved on: 
Wednesday, April 3, 2024
Banking, Asset Management, Professional Services, Finance, Narrative, Culture, Private equity, Partner (business rank), Publishing, Clarion, Creativity, Fund

Clarion Capital Partners, LLC (“Clarion” or the “Firm”) today announced it has closed its fourth fund, Clarion Investors IV, L.P. (“the Fund”) with $677 million in total capital commitments, exceeding its fundraising target of $600 million, as well as its $650 million soft cap.

Key Points: 
  • Clarion Capital Partners, LLC (“Clarion” or the “Firm”) today announced it has closed its fourth fund, Clarion Investors IV, L.P. (“the Fund”) with $677 million in total capital commitments, exceeding its fundraising target of $600 million, as well as its $650 million soft cap.
  • Additionally, Clarion announced the promotion of David Ragins to President of Private Equity.
  • Marc Utay, Founder, will continue to serve as Managing Partner and provide the firm’s strategic vision and leadership.
  • Clarion raised the Fund with the help of Paul, Weiss, Rifkind, Wharton, & Garrison LLP as legal counsel.

Narrative Strategies Announces Partnership with Clarion Capital Partners to Accelerate Its Evolution and Growth

Retrieved on: 
Thursday, February 15, 2024
Narrative, Fortune 500, The Narrative, Connolly, Williams & Connolly, PR, Clarion, History, Creativity, LLP, Research, Face, Partnership

WASHINGTON, Feb. 15, 2024 /PRNewswire/ -- Narrative Strategies, LLC ("Narrative") – an integrated public affairs and corporate reputation agency – announced it has accepted a strategic investment from Clarion Capital Partners, LLC ("Clarion"). Narrative's executive partners will maintain a significant ownership stake in the Company and continue leading operations, with founding partner Ken Spain serving as CEO.

Key Points: 
  • WASHINGTON, Feb. 15, 2024 /PRNewswire/ -- Narrative Strategies, LLC ("Narrative") – an integrated public affairs and corporate reputation agency – announced it has accepted a strategic investment from Clarion Capital Partners, LLC ("Clarion").
  • Clarion has a long and successful history of investing in the media, entertainment, and technology space.
  • This partnership with Clarion will accelerate our ability to navigate this new terrain successfully with additional capabilities, talent, and geographies."
  • Narrative Strategies was represented by BrightTower, a New York City-headquartered investment banking and M&A advisory services firm, which served as the exclusive financial advisor to Narrative Strategies in this transaction.

Clarion Clinics Open for Psychedelic-Assisted Treatments

Retrieved on: 
Thursday, February 1, 2024
PTSD, Post-traumatic stress disorder, Clarion, TGA, Prohibition of drugs, Therapeutic Goods Administration, Clinical trial, Environment, Patient, Safety, Depression, Psilocybin, TRD, MDMA, Authorization, Psychotherapy, Schedule, Pharmaceutical industry

MELBOURNE, Australia and NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc (Nasdaq: IXHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet needs is pleased to announce that Clarion Clinic’s co-Founder and Head of Psychiatry, Professor Suresh Sundram, has received Authorised Prescriber approval from the Therapeutic Goods Administration (TGA) to prescribe MDMA in the treatment of Post-traumatic Stress Disorder (PTSD) and psilocybin for Treatment-resistant Depression (TRD) at its first built-for-purpose clinic based in Melbourne, Australia, a city of approximately 5.2M people.

Key Points: 
  • Clarion Clinics’ built-for-purpose clinic in Melbourne is now open for treatment, and will begin screening patients immediately.
  • Clarion Clinics is a collaboration between Australia’s leading psychedelic-assisted therapy professionals and scientists, and Incannex.
  • Clarion Clinics, Abbottsford, will be the first dedicated psychedelic-assisted therapy clinic in Australia.
  • Clarion is at the leading edge of mental healthcare, has the right protocols, and an experienced team ready to help people through these challenging conditions,” Peter Widdows, Incannex Director responsible for Clarion Clinics, said.

Lumanity Reorganizes and Expands Strategic Consulting Capabilities

Retrieved on: 
Monday, January 22, 2024
Clarion, Organization, Consultant, Management consulting, Commercial

Boston, MA., January 22, 2024 – Lumanity, a global strategic services partner, is realigning its strategic consulting capabilities to help clients more effectively create and demonstrate the value of assets throughout the development and commercialization lifecycle.

Key Points: 
  • Boston, MA., January 22, 2024 – Lumanity, a global strategic services partner, is realigning its strategic consulting capabilities to help clients more effectively create and demonstrate the value of assets throughout the development and commercialization lifecycle.
  • In addition, Lumanity is realigning its Commercial, Medical Affairs, and Clinical and Regulatory Strategy teams into a single global Strategy Consulting capability.
  • Lumanity’s Strategy Consulting team helps clients identify and create value inflection points for their assets and organizations throughout the product lifecycle.
  • For more information on Lumanity’s strategic consulting capabilities, visit its website .

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Retrieved on: 
Thursday, December 21, 2023
Psilocybin, Atypical depression, Post-traumatic stress disorder, Treatment, FDA, Ethics, MDMA, PTSD, TGA, Clarion, Authorization, IHL, Patient, Therapeutic Goods Administration, TRD, Environment, Pharmaceutical industry

MELBOURNE, Australia and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet needs is pleased to announce that it has received ethics board endorsement for psychedelic assisted therapy at its first clinic based in Melbourne, Australia, a city of approximately 5.2M people.

Key Points: 
  • Incannex subsidiary, Clarion Clinics, has received Human Research Ethics Committee (HREC) endorsement for administration of psychedelic-assisted therapies for TRD and PTSD.
  • Clarion Clinics is the only dedicated psychedelic-assisted therapy clinic in Australia, with intentions to open more clinics across the country and internationally as legislation permits.
  • Clarion Clinics team includes pre-eminent psychedelic researchers, psychologists and psychiatrists whose expertise can not easily be replicated in Australia.
  • The Melbourne Clarion Clinic will be the first dedicated Psychedelic-assisted therapy clinic in Australia.

Kimberly Adams to Join Clarion Partners as Managing Director

Retrieved on: 
Tuesday, November 14, 2023
Commercial Building & Real Estate, Construction & Property, Professional Services, Finance, Partner, LaSalle Investment Management, Prudential Financial, JPMorgan Chase, Clarion Partners, Clarion

Clarion Partners, LLC, a leading real estate investment manager, announced today that Kimberly Adams will be joining the Firm’s senior leadership team as a Managing Director in early 2024.

Key Points: 
  • Clarion Partners, LLC, a leading real estate investment manager, announced today that Kimberly Adams will be joining the Firm’s senior leadership team as a Managing Director in early 2024.
  • Adams joins Clarion after more than 20 years with JPMorgan where, for the last 10 years, she led the portfolio management team of its $40B+ flagship real estate investment strategy.
  • Previously, Ms. Adams had been focused on asset management and acquisitions for JPMorgan, Prudential Real Estate, and LaSalle Investment Management.
  • “We are very pleased to have Kim join Clarion’s senior management team and add specific focus to investing in alternative property sectors,” commented Clarion CEO David Gilbert.

Greg Topalian Joins SportsGrid Board of Directors, to Lead Fan Experiences

Retrieved on: 
Tuesday, December 12, 2023
Television, Awesome Con, Acquisition, New York Comic Con, B2B, Business development, RELX, Clarion, Fire, Dan Abrams, PAX (event), Growth, Knowledge, Sport, Entertainment, Video game, Insurance

With over 25 years of experience of leading innovation in both fan-based and B2B live events, Greg Topalian brings a wealth of knowledge and a track record of success to the SportsGrid executive team.

Key Points: 
  • With over 25 years of experience of leading innovation in both fan-based and B2B live events, Greg Topalian brings a wealth of knowledge and a track record of success to the SportsGrid executive team.
  • In his new board role, Greg will lead the company's efforts in enhancing fan experiences, further cementing SportsGrid's commitment to delivering unparalleled engagement to sports fans.
  • "I'm excited to join the board of SportsGrid and contribute to the company's growth and success in this dynamic industry," said Greg Topalian.
  • With Greg Topalian joining the Board of Directors and leading fan experiences, SportsGrid is poised to further expand its presence in the sports media and entertainment space and continue delivering cutting-edge content and unforgettable experiences to sports enthusiasts worldwide.

Clarion Technologies Strengthens Java and Python Development Services, Integrating AI, DevOps, Cloud, and Mobility for Enhanced Innovation and Scalability

Retrieved on: 
Friday, December 1, 2023
Cloud, PEP, Android, Clarion, IP, Language, Innovation, Python, Ecosystem, Documentation, Deeplearning4j, Library, DevOps, Business, AWS, Model, Computer data storage, Medical device, Online shopping, Satellite navigation device, Java

NEW YORK, Dec. 1, 2023 /PRNewswire-PRWeb/ -- Clarion Technologies extends its Java and Python expertise, supporting small to medium businesses and cloud-native digital start-up ecosystems. The company offers cost-optimized, high-performing offshore software development solutions, effectively elevating operations and scaling efficiency. Clarion Technologies specializes in delivering customized services designed to meet the distinctive needs of businesses, solidifying its commitment to facilitating their growth journey.

Key Points: 
  • Clarion Technologies enhances Java and Python proficiency to support small to medium businesses and cloud-native startups, providing cost-optimized offshore software development solutions.
  • NEW YORK, Dec. 1, 2023 /PRNewswire-PRWeb/ -- Clarion Technologies extends its Java and Python expertise, supporting small to medium businesses and cloud-native digital start-up ecosystems.
  • Implementing Java Best Practices: Clarion Technologies seamlessly integrates best practices for Java, ensuring clean code, optimal structure, and effective utilization of language features in Java software development services .
  • Resource Utilization with Python: Clarion Technologies maximizes development resources by harnessing Python's data science and automation capabilities, driving efficiency and innovation.

Growth Acceleration Partners Announces Support for .NET 8 with Mobilize Modernization Solutions

Retrieved on: 
Tuesday, November 14, 2023
Windows Forms, GAP, VB.NET, PowerBuilder, Clarion, Modernization theory, Conf

AUSTIN, Texas, Nov. 14, 2023 /PRNewswire/ -- Growth Acceleration Partners (GAP), a strategic technology leader for consulting, designing, and building specialized software and data solutions, announces its support for .NET 8 through its popular Mobilize Modernization Solutions. New features include:

Key Points: 
  • AUSTIN, Texas, Nov. 14, 2023 /PRNewswire/ -- Growth Acceleration Partners (GAP) , a strategic technology leader for consulting, designing, and building specialized software and data solutions, announces its support for .NET 8 through its popular Mobilize Modernization Solutions.
  • New features include:
    All products, including WebMAP, now offer full support for .NET 8, accommodating a range of technologies such as Clarion, PowerBuilder, C# Winforms, VB.NET, among others.
  • VBUC introduces type library substitution for missing references, allowing projects to migrate to .NET 8 with greater ease
    "At GAP, our vision extends beyond the current landscape to redefine technology modernization.
  • The Mobilize Modernization product line stands as a testament to this mission, successfully migrating billions of lines of code and modernizing thousands of legacy applications," said Darryl Worsham, General Manager of the Modernize & Mobilize business unit at GAP.

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Retrieved on: 
Tuesday, August 8, 2023
Depression, Q3, Royal Australian and New Zealand College of Psychiatrists, Quality of life, ASX, Diagnosis, PAT, PTSD, Nursing, Pharmaceutical industry, Clarion, Psychotherapy

MELBOURNE, Australia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet needs is pleased to announce that its subsidiary, Clarion Clinics Group Pty Ltd, is now accepting direct registration of interest in treatment from potential clients via its website at clarionclinics.com ahead of its planned Q3 opening.

Key Points: 
  • Incannex subsidiary, Clarion Clinics Group Pty Ltd (Clarion) begins accepting registrations of interest in its psychedelic-assisted therapy (PAT) treatments ahead of planned Q3 opening.
  • If accepted for treatment, clients will be treated for nine-months at a Clarion Clinic.
  • People who have an interest in treatment from Clarion can now register and request further information on the Clarion website.
  • At Clarion Clinics, our aim is to achieve the best outcomes possible using psychedelic therapies, through tailored and extended protocols and a brilliant team,” Dr. Paul Liknaitzky said.